Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ALTRAPHARMA Invest ApS
APS
Active
Advertising protection
CVR 34483884
Storkevænget 9, 2840
Holte
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2012 · 14 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
ALTRAPHARMA Invest ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-76
-172
-67
-43
-89
Staff expenses
-91
-304
-0
-0
-20
EBITDA
-167
-476
-67
-43
-109
Depreciation & amort.
-5
-6
-0
-0
-0
EBIT
-171
-482
-67
-43
-109
Net financials
-1
-3
-0
0
0
Profit before tax
-173
-486
-67
-43
-109
Tax
-27
-1
-0
-129
-24
Net profit
-146
-484
-67
87
-85
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
808
249
182
240
145
Equity
554
69
2
89
104
Long-term debt
0
0
0
0
0
Short-term debt
253
180
179
151
41
Total debt
253
180
179
151
41
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-10866500.0%
This company
2021
2025
Equity ratio
71.5%
This company
38.2%
Market median
+87% vs market
2021
2025
Return on equity
-81.9%
This company
18.4%
Market median
-545% vs market
2021
2025
Net profit margin (of gross profit)
-8494400.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.61×
This company
2021
2025
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on ALTRAPHARMA Invest ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
